SG Stock MarketDetailed Quotes

42C IX Biopharma

Watchlist
  • 0.023
  • 0.0000.00%
10min DelayMarket Closed Dec 2 15:28 CST
20.32MMarket Cap-1916P/E (TTM)

IX Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(Q2)Dec 31, 2019
(Q1)Sep 30, 2019
(FY)Jun 30, 2019
(Q4)Jun 30, 2019
(Q3)Mar 31, 2019
(Q2)Dec 31, 2018
Total revenue
-58.91%5.91M
724.64%14.39M
77.16%1.75M
46.80%985K
62.62%174K
18.81%120K
172.76%671K
-92.21%129K
254.26%333K
-93.90%107K
Cost of revenue
71.10%3.59M
-1.27%2.1M
35.31%2.13M
31.00%1.57M
125.68%334K
74.02%355K
143.41%1.2M
-76.95%343K
271.85%502K
-87.38%148K
Gross profit
-81.12%2.32M
3,317.28%12.29M
34.92%-382K
-10.96%-587K
-290.24%-160K
-128.16%-235K
-114.17%-529K
-228.14%-214K
-312.20%-169K
-107.07%-41K
Operating expense
-2.60%10.73M
14.19%11.02M
-7.39%9.65M
-8.24%10.42M
-18.15%2.58M
-18.12%2.5M
-26.32%11.35M
-56.90%2.39M
-17.85%2.76M
-8.61%3.15M
Selling and administrative expenses
-4.37%9.04M
13.94%9.46M
-3.54%8.3M
9.69%8.61M
4.69%2.28M
19.38%2.01M
6.09%7.85M
-16.14%1.87M
21.37%2.12M
-0.32%2.17M
-Selling and marketing expense
52.96%3.17M
-7.74%2.08M
-0.44%2.25M
11.61%2.26M
-9.35%543K
55.77%648K
19.69%2.02M
-2.58%566K
9.93%443K
4.72%599K
-General and administrative expense
-20.48%5.87M
22.00%7.38M
-4.65%6.05M
9.02%6.35M
10.03%1.73M
7.42%1.36M
2.05%5.82M
-20.94%1.3M
24.80%1.68M
-2.11%1.58M
Research and development costs
20.93%2.82M
-15.11%2.33M
9.92%2.75M
-33.63%2.5M
-46.57%522K
-48.04%715K
-53.12%3.77M
-76.48%780K
-60.62%632K
-22.89%977K
Total other operating income
46.76%1.13M
-44.82%772K
103.94%1.4M
166.93%686K
--219K
--219K
1,411.76%257K
----
----
----
Operating profit
-760.72%-8.41M
112.69%1.27M
8.86%-10.03M
7.38%-11.01M
14.19%-2.74M
13.35%-2.74M
24.11%-11.88M
51.57%-2.6M
13.87%-2.93M
-11.30%-3.19M
Net non-operating interest income expense
-30.69%-264K
-20.96%-202K
-10.60%-167K
-297.37%-151K
6.56%-57K
-3.33%-62K
-40.74%-38K
310.61%139K
-67.65%-57K
7.58%-61K
Non-operating interest income
--7K
--0
-91.95%7K
-55.15%87K
----
----
-13.00%194K
----
----
----
Non-operating interest expense
34.16%271K
16.09%202K
-26.89%174K
2.59%238K
-6.56%57K
3.33%62K
-7.20%232K
-16.67%55K
67.65%57K
-7.58%61K
Net investment income
-45.11%-2.77M
-206.46%-1.91M
367.45%1.8M
123.19%384K
-52.63%-1.66M
Gain/Loss on financial instruments designated as cash flow hedges
Gain/Loss on derecognition of available-for-sale financial assets
153.45%1.74M
-3.26M
0
Income from associates and other participating interests
Special income /charges
Other non-operating income /expenses
-38.10%169K
-11.36%273K
212.24%376K
-315.27%-544K
-79.91%308K
-41.24%644K
118.95%130K
-1.52%-335K
Income before tax
-136.79%-9.71M
50.21%-4.1M
21.58%-8.23M
20.87%-10.5M
32.55%-2.42M
0.21%-3.35M
12.91%-13.27M
19.99%-3.48M
30.71%-2.85M
-9.93%-3.59M
Income tax
-118.24%-91K
49,800.00%499K
1K
0
0
0
-142.31%-22K
-51.72%14K
44.12%-19K
39.29%-17K
Net income
-109.11%-9.62M
44.16%-4.6M
21.57%-8.23M
-251.02%-10.5M
32.82%-2.42M
-3.21%-3.35M
80.18%-2.99M
13.79%-3.77M
277.27%7.62M
-11.31%-3.6M
Net income continuous operations
-109.11%-9.62M
44.16%-4.6M
21.57%-8.23M
20.74%-10.5M
32.23%-2.42M
0.21%-3.35M
13.35%-13.25M
20.20%-3.49M
30.60%-2.83M
-10.35%-3.57M
Net income discontinuous operations
----
----
----
----
--0
--0
5,213.47%10.26M
---280K
4,917.51%10.45M
---31K
Noncontrolling interests
Net income attributable to the company
-109.11%-9.62M
44.16%-4.6M
21.57%-8.23M
-251.02%-10.5M
32.82%-2.42M
-3.21%-3.35M
80.18%-2.99M
13.79%-3.77M
277.27%7.62M
-11.31%-3.6M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-109.11%-9.62M
44.16%-4.6M
21.57%-8.23M
-251.02%-10.5M
32.82%-2.42M
-3.21%-3.35M
80.18%-2.99M
13.79%-3.77M
277.27%7.62M
-11.31%-3.6M
Gross dividend payment
Basic earnings per share
-103.23%-0.0125
47.90%-0.0061
26.54%-0.0118
-248.88%-0.016
33.49%-0.3614
-2.83%-0.508
80.23%-0.0046
16.67%-0.0058
276.13%0.0117
-10,899.82%-0.5434
Diluted earnings per share
-103.23%-0.0125
47.90%-0.0061
26.54%-0.0118
-248.88%-0.016
33.49%-0.3614
-2.83%-0.508
80.23%-0.0046
16.67%-0.0058
274.63%0.0116
-10,899.82%-0.5434
Dividend per share
Currency Unit
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(Q2)Dec 31, 2019(Q1)Sep 30, 2019(FY)Jun 30, 2019(Q4)Jun 30, 2019(Q3)Mar 31, 2019(Q2)Dec 31, 2018
Total revenue -58.91%5.91M724.64%14.39M77.16%1.75M46.80%985K62.62%174K18.81%120K172.76%671K-92.21%129K254.26%333K-93.90%107K
Cost of revenue 71.10%3.59M-1.27%2.1M35.31%2.13M31.00%1.57M125.68%334K74.02%355K143.41%1.2M-76.95%343K271.85%502K-87.38%148K
Gross profit -81.12%2.32M3,317.28%12.29M34.92%-382K-10.96%-587K-290.24%-160K-128.16%-235K-114.17%-529K-228.14%-214K-312.20%-169K-107.07%-41K
Operating expense -2.60%10.73M14.19%11.02M-7.39%9.65M-8.24%10.42M-18.15%2.58M-18.12%2.5M-26.32%11.35M-56.90%2.39M-17.85%2.76M-8.61%3.15M
Selling and administrative expenses -4.37%9.04M13.94%9.46M-3.54%8.3M9.69%8.61M4.69%2.28M19.38%2.01M6.09%7.85M-16.14%1.87M21.37%2.12M-0.32%2.17M
-Selling and marketing expense 52.96%3.17M-7.74%2.08M-0.44%2.25M11.61%2.26M-9.35%543K55.77%648K19.69%2.02M-2.58%566K9.93%443K4.72%599K
-General and administrative expense -20.48%5.87M22.00%7.38M-4.65%6.05M9.02%6.35M10.03%1.73M7.42%1.36M2.05%5.82M-20.94%1.3M24.80%1.68M-2.11%1.58M
Research and development costs 20.93%2.82M-15.11%2.33M9.92%2.75M-33.63%2.5M-46.57%522K-48.04%715K-53.12%3.77M-76.48%780K-60.62%632K-22.89%977K
Total other operating income 46.76%1.13M-44.82%772K103.94%1.4M166.93%686K--219K--219K1,411.76%257K------------
Operating profit -760.72%-8.41M112.69%1.27M8.86%-10.03M7.38%-11.01M14.19%-2.74M13.35%-2.74M24.11%-11.88M51.57%-2.6M13.87%-2.93M-11.30%-3.19M
Net non-operating interest income expense -30.69%-264K-20.96%-202K-10.60%-167K-297.37%-151K6.56%-57K-3.33%-62K-40.74%-38K310.61%139K-67.65%-57K7.58%-61K
Non-operating interest income --7K--0-91.95%7K-55.15%87K---------13.00%194K------------
Non-operating interest expense 34.16%271K16.09%202K-26.89%174K2.59%238K-6.56%57K3.33%62K-7.20%232K-16.67%55K67.65%57K-7.58%61K
Net investment income -45.11%-2.77M-206.46%-1.91M367.45%1.8M123.19%384K-52.63%-1.66M
Gain/Loss on financial instruments designated as cash flow hedges
Gain/Loss on derecognition of available-for-sale financial assets 153.45%1.74M-3.26M0
Income from associates and other participating interests
Special income /charges
Other non-operating income /expenses -38.10%169K-11.36%273K212.24%376K-315.27%-544K-79.91%308K-41.24%644K118.95%130K-1.52%-335K
Income before tax -136.79%-9.71M50.21%-4.1M21.58%-8.23M20.87%-10.5M32.55%-2.42M0.21%-3.35M12.91%-13.27M19.99%-3.48M30.71%-2.85M-9.93%-3.59M
Income tax -118.24%-91K49,800.00%499K1K000-142.31%-22K-51.72%14K44.12%-19K39.29%-17K
Net income -109.11%-9.62M44.16%-4.6M21.57%-8.23M-251.02%-10.5M32.82%-2.42M-3.21%-3.35M80.18%-2.99M13.79%-3.77M277.27%7.62M-11.31%-3.6M
Net income continuous operations -109.11%-9.62M44.16%-4.6M21.57%-8.23M20.74%-10.5M32.23%-2.42M0.21%-3.35M13.35%-13.25M20.20%-3.49M30.60%-2.83M-10.35%-3.57M
Net income discontinuous operations ------------------0--05,213.47%10.26M---280K4,917.51%10.45M---31K
Noncontrolling interests
Net income attributable to the company -109.11%-9.62M44.16%-4.6M21.57%-8.23M-251.02%-10.5M32.82%-2.42M-3.21%-3.35M80.18%-2.99M13.79%-3.77M277.27%7.62M-11.31%-3.6M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -109.11%-9.62M44.16%-4.6M21.57%-8.23M-251.02%-10.5M32.82%-2.42M-3.21%-3.35M80.18%-2.99M13.79%-3.77M277.27%7.62M-11.31%-3.6M
Gross dividend payment
Basic earnings per share -103.23%-0.012547.90%-0.006126.54%-0.0118-248.88%-0.01633.49%-0.3614-2.83%-0.50880.23%-0.004616.67%-0.0058276.13%0.0117-10,899.82%-0.5434
Diluted earnings per share -103.23%-0.012547.90%-0.006126.54%-0.0118-248.88%-0.01633.49%-0.3614-2.83%-0.50880.23%-0.004616.67%-0.0058274.63%0.0116-10,899.82%-0.5434
Dividend per share
Currency Unit SGDSGDSGDSGDSGDSGDSGDSGDSGDSGD
Heat List
SG
Overall
Symbol
Latest Price
% Chg

No Data